Lewy body disease is the second most common neurodegenerative disease after Alzheimer’s disease. A research group from Lund University has now shown that the disease
ArsenalBio’s pipeline comprises potential therapies being developed for treating solid tumours. Credit: shisu_ka/Shutterstock. ArsenalBio has closed an oversubscribed Series C financing round, securing $325m to
As the spotlight trains on access to biosimilars, Novartis’ generics unit on Thursday released a global action plan to boost biosimilar adoption by 2030. The